Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, Rameix-Welti MA, Josset L, Bal A; collaborative group; Bichat; Houhou N, Guilbaud R, Saint-Joannis T; Bordeaux; La Pitié-Salpêtrière; Marseille; Mondor; Reims; Rennes; Rouen; Saint-Louis; Toulon; Poggi C, Toyer AL, Domine M, Gardan V; Toulouse; Carcenac R, Demmou S, Latour J, Vellas C; Tours; Lyon; Pasteur; ANRS-MIE Technology working group. Moisan A, et al. Among authors: le hingrat q. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00605-0. doi: 10.1016/j.cmi.2024.12.018. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725080 No abstract available.
Monkeypox clade IIb in France in 2023-2024.
Rahi M, Fouere S, Gilbert M, Bachelard A, Taieb F, Sellem B, Herms F, Cazanave C, Valin N, Monsel G, Yazdanpanah Y, Ghosn J, Peiffer-Smadja N; MPV 23-24 Study group. Rahi M, et al. Lancet Reg Health Eur. 2024 Oct 25;47:101114. doi: 10.1016/j.lanepe.2024.101114. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39526296 Free PMC article. No abstract available.
Long Covid: a global health issue - a prospective, cohort study set in four continents.
Pazukhina E, Garcia-Gallo E, Reyes LF, Kildal AB, Jassat W, Dryden M, Holter JC, Chatterjee A, Gomez K, Søraas A, Puntoni M, Latronico N, Bozza FA, Edelstein M, Gonçalves BP, Kartsonaki C, Kruglova O, Gaião S, Chow YP, Doshi Y, Duque Vallejo SI, Ibáñez-Prada ED, Fuentes YV, Hastie C, O'Hara ME, Balan V, Menkir T, Merson L, Kelly S, Citarella BW, Semple MG, Scott JT, Munblit D, Sigfrid L; ISARIC Clinical Characterisation Group and ISARIC Global Covid-19 follow up working group. Pazukhina E, et al. BMJ Glob Health. 2024 Oct 21;9(10):e015245. doi: 10.1136/bmjgh-2024-015245. BMJ Glob Health. 2024. PMID: 39433402 Free PMC article.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results.
Serris A, Ferre VM, Le Hingrat Q, Bachelard A, Charpentier C, Exarchopoulos M, Damond F, Phung BC, Landman R, Yazdanpanah Y, Descamps D, Joly V, Peytavin G, Ghosn J. Serris A, et al. Among authors: le hingrat q. J Antimicrob Chemother. 2024 Nov 4;79(11):2932-2938. doi: 10.1093/jac/dkae308. J Antimicrob Chemother. 2024. PMID: 39287977
Immuno-virological and Clinical Follow-up of Persons Living With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study.
Joly V, Ferre VM, Le Hingrat Q, Peytavin G, Cresta M, Charpentier C, Digumber M, Damond F, Yazdanpanah Y, Matheron S, Descamps D, Ghosn J. Joly V, et al. Among authors: le hingrat q. Clin Infect Dis. 2024 Sep 16:ciae447. doi: 10.1093/cid/ciae447. Online ahead of print. Clin Infect Dis. 2024. PMID: 39283963
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
de Prost N, Audureau E, Guillon A, Handala L, Préau S, Guigon A, Uhel F, Le Hingrat Q, Delamaire F, Grolhier C, Tamion F, Moisan A, Darreau C, Thomin J, Contou D, Henry A, Daix T, Hantz S, Saccheri C, Giordanengo V, Pham T, Chaghouri A, Bay P, Pawlotsky JM, Fourati S; SEVARVIR investigators. de Prost N, et al. Among authors: le hingrat q. Ann Intensive Care. 2024 Jun 28;14(1):101. doi: 10.1186/s13613-024-01319-w. Ann Intensive Care. 2024. PMID: 38940865 Free PMC article.
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Citarella BW, Kartsonaki C, Ibáñez-Prada ED, Gonçalves BP, Baruch J, Escher M, Pritchard MG, Wei J, Philippy F, Dagens A, Hall M, Lee J, Kutsogiannis DJ, Wils EJ, Fernandes MA, Tirupakuzhi Vijayaraghavan BK, Panda PK, Martin-Loeches I, Ohshimo S, Fatoni AZ, Horby P, Dunning J, Rello J, Merson L, Rojek A, Vaillant M, Olliaro P, Reyes LF; ISARIC Clinical Characterisation Group. Citarella BW, et al. Heliyon. 2024 May 4;10(10):e29591. doi: 10.1016/j.heliyon.2024.e29591. eCollection 2024 May 30. Heliyon. 2024. PMID: 38779000 Free PMC article.
Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France.
Mokrani D, Le Hingrat Q, Thy M, Choquet C, Joly V, Lariven S, Rioux C, Deconinck L, Loubet P, Papo T, Crestani B, Bunel V, Bouadma L, Khalil A, Armand-Lefèvre L, Raynaud-Simon A, Timsit JF, Lescure FX, Yazdanpanah Y, Descamps D, Peiffer-Smadja N. Mokrani D, et al. Among authors: le hingrat q. J Infect. 2024 Jul;89(1):106180. doi: 10.1016/j.jinf.2024.106180. Epub 2024 May 15. J Infect. 2024. PMID: 38759759 Free article.
Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.
Konu YR, Takassi E, Peytavin G, Dapam N, Damond F, Oumarou WA, Zaidi M, Franco-Yusti AM, Dagnra CA, Le Hingrat Q, Coppée R, Descamps D, Diallo FBT, Ekouevi DK, Charpentier C. Konu YR, et al. Among authors: le hingrat q. Clin Infect Dis. 2024 May 15:ciae278. doi: 10.1093/cid/ciae278. Online ahead of print. Clin Infect Dis. 2024. PMID: 38748464
95 results